Novel tool can estimate number of T cells in cancer tumours
Researchers have developed a new method that can rapidly count the number of T cells in a tumour, helping to predict patient response to therapies.
List view / Grid view
Researchers have developed a new method that can rapidly count the number of T cells in a tumour, helping to predict patient response to therapies.
Researchers have turned human stem cells into brain cells to create a new model that can predict cognitive decline rate on an individualised level.
A potential drug to treat a subset of gastrointestinal stroma tumours (GIST) have been found to tackle intestinal tract cancer.
Hear about the latest Drug Target Review updates from Deputy Editor Victoria Rees who discusses our new report on AI & Informatics, the Cell & Gene Therapy Advancements online summit and much more!
This whitepaper overviews use of Advanced Flow Cytometry to accelerate antibody screening and characterisation and reveal deeper biological insights.
A team have found that two DNA changes appear to predict acute lymphoblastic leukaemia, illuminating genetic understanding of the disease.
This whitepaper describes several live-cell phenotypic analyses suitable for the characterisation of astroglia cells.
Accelerate the discovery process of new drugs and targets with a better understanding of the metabolome and lipidome during drug development.
The latest edition of the live-cell analysis handbook is a companion guide for live-cell analysis users. Includes discussion of live-cell analysis.
A novel synthetic “switch” has been developed that could hold the key to revolutionary smart insulin therapy for diabetic patients.
This whitepaper overviews the importance of understanding T Cell Biology to build better therapeutics, demonstrates use of advanced flow cytometry.
JDRF funds development of an insulin-producing implant to regulate blood glucose levels in type 1 diabetes patients.
28 July 2021 | By Sartorius AG
In this on-demand webinar, our expert illustrates the utility of GPCR libraries and explains how to discover potent functional antibodies against multiple GPCR targets.
Researchers have used patient-specific tumour organoid models to improve immunotherapy treatments for appendiceal cancer.
Research by a team in Canada reveals a promising therapeutic target to counter HER2-positive breast cancer.